Yahoo
OTC Markets OTCPK - Delayed Quote USD

Mymetics Corporation (MYMX)

0.0003 0.0000 (0.00%)
At close: October 30 at 5:00:00 PM EDT
Chart Range Bar
Loading chart for MYMX
  • Previous Close 0.0003
  • Open 0.0003
  • Bid --
  • Ask --
  • Day's Range 0.0003 - 0.0003
  • 52 Week Range 0.0003 - 0.0003
  • Volume 100
  • Avg. Volume 0
  • Market Cap (intraday) 45
  • Beta (5Y Monthly) 2.39
  • PE Ratio (TTM) --
  • EPS (TTM) -106.7000
  • Earnings Date --
  • Forward Dividend & Yield -- (0.00%)
  • Ex-Dividend Date --
  • 1y Target Est --

Mymetics Corporation engages in the research and development of vaccines for infectious and life disabling diseases in Switzerland. The company's product pipeline includes various vaccine candidates, such as HIV-1/AIDS, Covid-19, intra nasal influenza, respiratory syncytial virus, and malaria. Mymetics Corporation has a collaboration agreement with Texas Biomedical Research Institute; and national institutes of health. The company was formerly known as ICHOR Corporation and changed its name to Mymetics Corporation in July 2001. Mymetics Corporation was founded in 1990 and is based in Epalinges, Switzerland.

www.mymetics.com

2

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Biotechnology

Industry

Recent News

View More

Performance Overview

Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

MYMX
0.00%
S&P 500 (^GSPC)
10.73%

1-Year Return

MYMX
0.00%
S&P 500 (^GSPC)
11.11%

3-Year Return

MYMX
99.98%
S&P 500 (^GSPC)
81.91%

5-Year Return

MYMX
100.00%
S&P 500 (^GSPC)
64.59%

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -29.12%

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    533k

  • Net Income Avi to Common (ttm)

    -11.57M

  • Diluted EPS (ttm)

    -106.7000

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    62k

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    -2.18M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: